Factors associated with long-term renal allograft survival

Bruce Kaplan, Titte R. Srinivas, Herwig Ulf Meier-Kriesche

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Major advances in immunosuppression and reductions in the rates of acute rejection have led to increasing graft and patient survival rates during the past two decades. Chronic dysfunction of the renal allograft, however, remains a major clinical problem and probably represents the end result of the complex interplay between donor and recipient factors, immunologic injury, nonimmunologic insults, and drug-induced nephrotoxicity. Optimal function of the renal allograft is obtained by maintaining a balance between underimmunosuppression and acute rejection and overimmunosuppression and drug-induced toxicities. To minimize side effects while maintaining efficacy, immunosuppressive drugs are commonly used as combination therapy. Pharmacokinetic and pharmacodynamic interactions between these agents can affect graft survival and function. The evidence supporting the role of therapeutic drug monitoring as applied to commonly used immunosuppressants in modem transplantation is presented here, and the increasing role of therapeutic drug monitoring in the optimization of graft and patient survival rates in the modern era of renal transplantation is discussed.

Original languageEnglish (US)
Pages (from-to)36-39
Number of pages4
JournalTherapeutic Drug Monitoring
Volume24
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Graft Survival
Allografts
Drug Monitoring
Immunosuppressive Agents
Kidney
Grafts
Survival Rate
Pharmaceutical Preparations
Modems
Immunologic Factors
Drug-Related Side Effects and Adverse Reactions
Kidney Transplantation
Immunosuppression
Pharmacodynamics
Pharmacokinetics
Transplantation
Tissue Donors
Monitoring
Wounds and Injuries
Toxicity

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis
  • Pharmacology
  • Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology (medical)
  • Public Health, Environmental and Occupational Health

Cite this

Factors associated with long-term renal allograft survival. / Kaplan, Bruce; Srinivas, Titte R.; Meier-Kriesche, Herwig Ulf.

In: Therapeutic Drug Monitoring, Vol. 24, No. 1, 2002, p. 36-39.

Research output: Contribution to journalArticle

Kaplan, Bruce ; Srinivas, Titte R. ; Meier-Kriesche, Herwig Ulf. / Factors associated with long-term renal allograft survival. In: Therapeutic Drug Monitoring. 2002 ; Vol. 24, No. 1. pp. 36-39.
@article{bb014f98924b4047879c65a3cd3f2130,
title = "Factors associated with long-term renal allograft survival",
abstract = "Major advances in immunosuppression and reductions in the rates of acute rejection have led to increasing graft and patient survival rates during the past two decades. Chronic dysfunction of the renal allograft, however, remains a major clinical problem and probably represents the end result of the complex interplay between donor and recipient factors, immunologic injury, nonimmunologic insults, and drug-induced nephrotoxicity. Optimal function of the renal allograft is obtained by maintaining a balance between underimmunosuppression and acute rejection and overimmunosuppression and drug-induced toxicities. To minimize side effects while maintaining efficacy, immunosuppressive drugs are commonly used as combination therapy. Pharmacokinetic and pharmacodynamic interactions between these agents can affect graft survival and function. The evidence supporting the role of therapeutic drug monitoring as applied to commonly used immunosuppressants in modem transplantation is presented here, and the increasing role of therapeutic drug monitoring in the optimization of graft and patient survival rates in the modern era of renal transplantation is discussed.",
author = "Bruce Kaplan and Srinivas, {Titte R.} and Meier-Kriesche, {Herwig Ulf}",
year = "2002",
doi = "10.1097/00007691-200202000-00007",
language = "English (US)",
volume = "24",
pages = "36--39",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Factors associated with long-term renal allograft survival

AU - Kaplan, Bruce

AU - Srinivas, Titte R.

AU - Meier-Kriesche, Herwig Ulf

PY - 2002

Y1 - 2002

N2 - Major advances in immunosuppression and reductions in the rates of acute rejection have led to increasing graft and patient survival rates during the past two decades. Chronic dysfunction of the renal allograft, however, remains a major clinical problem and probably represents the end result of the complex interplay between donor and recipient factors, immunologic injury, nonimmunologic insults, and drug-induced nephrotoxicity. Optimal function of the renal allograft is obtained by maintaining a balance between underimmunosuppression and acute rejection and overimmunosuppression and drug-induced toxicities. To minimize side effects while maintaining efficacy, immunosuppressive drugs are commonly used as combination therapy. Pharmacokinetic and pharmacodynamic interactions between these agents can affect graft survival and function. The evidence supporting the role of therapeutic drug monitoring as applied to commonly used immunosuppressants in modem transplantation is presented here, and the increasing role of therapeutic drug monitoring in the optimization of graft and patient survival rates in the modern era of renal transplantation is discussed.

AB - Major advances in immunosuppression and reductions in the rates of acute rejection have led to increasing graft and patient survival rates during the past two decades. Chronic dysfunction of the renal allograft, however, remains a major clinical problem and probably represents the end result of the complex interplay between donor and recipient factors, immunologic injury, nonimmunologic insults, and drug-induced nephrotoxicity. Optimal function of the renal allograft is obtained by maintaining a balance between underimmunosuppression and acute rejection and overimmunosuppression and drug-induced toxicities. To minimize side effects while maintaining efficacy, immunosuppressive drugs are commonly used as combination therapy. Pharmacokinetic and pharmacodynamic interactions between these agents can affect graft survival and function. The evidence supporting the role of therapeutic drug monitoring as applied to commonly used immunosuppressants in modem transplantation is presented here, and the increasing role of therapeutic drug monitoring in the optimization of graft and patient survival rates in the modern era of renal transplantation is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0036146485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036146485&partnerID=8YFLogxK

U2 - 10.1097/00007691-200202000-00007

DO - 10.1097/00007691-200202000-00007

M3 - Article

VL - 24

SP - 36

EP - 39

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 1

ER -